Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Clinical Trials / Drug Trials News

More Participants Sought For Study Of Prolotherapy For Tennis Elbow At UPMC

Main Category: Clinical Trials / Drug Trials
Also Included In: Pain / Anesthetics;  Rehabilitation / Physical Therapy
Article Date: 25 Jul 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:5 stars

5 (1 votes)

Article Opinions: 0 posts

The Center for Integrative Medicine (CIM) at the University of Pittsburgh Medical Center (UPMC) is seeking participants for a study to evaluate the benefits of prolotherapy for tennis elbow.

Prolotherapy is a non-surgical treatment used to stimulate repair of damaged ligaments and tendons. It uses an irritant such as a sugar-based solution that is injected into the deep tissue structures. This causes a localized inflammation, which then causes the tendons and ligaments to repair and strengthen themselves. As the tissues repair they get stronger, which can lead to a reduction in pain.

Tennis elbow, or lateral epicondylitis, is an overuse injury in which a repetitive activity such as tennis or lifting causes pain on the outside of the elbow.

Researchers are seeking people between the ages of 18 and 65 who currently are experiencing tennis elbow to participate in the study, entitled, "Prolotherapy for the treatment of chronic lateral epicondylitis," which is funded by the National Institutes of Health. Participants will be evaluated at the CIM by a sports medicine specialist to confirm their diagnosis, and will fill out questionnaires about their pain level before continuing with the study. They will receive three to six injections, each approximately three weeks apart. The response to these treatments will be monitored for an additional 12 weeks. Participants will be compensated for their time.

For more information and to find out if you qualify for the study, please call the CIM at (412) 623-2374 or visit the Web site at http://integrativemedicine.upmc.com.

The CIM is dedicated to clinical services, education and research on an evolving form of health care where disease prevention, practitioner/patient partnership and the evidence-based application of non-conventional treatment strategies are explored in collaboration with conventional medical practices.

Source:
University of Pittsburgh Medical Center
http://www.upmc.com




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available For Relief Of Moderate To Severe Acute Pain
24 Jun 2009
Patients suffering from acute pain and healthcare professionals who treat pain have a new treatment option: NUCYNTA(TM) (tapentadol) CII immediate release tablets. This new medication for the relief of moderate to severe...


Flossing Your Teeth The Right Way
Flossing Your Teeth The Right Way

Flossing is important for a healthy mouth. But to get the most benefit without causing pain, you need to know how to do it the right way.

more videos are available in our health videos section.